Raymond Chan, Deputy Vice-Chancellor of Research at Flinders University, shared a post on LinkedIn: about a paper by Adam K. Walker et al. published in Brain, Behavior, and Immunity:
“Cancer-related cognitive impairment affects up to 75 % of cancer patients. This study is the first to show targeting the RAS may be a viable strategy for alleviating cancer-related cognitive impairment.”
Title: Candesartan, an angiotensin receptor blocker, prevents cognitive impairment in female mice with mammary cancer
Authors: Delyse McCaffrey, Yasmine Kostoglou, Alan Tao, Raymond J. Chan, Janette L. Vardy, Alexandre Chan, Teri Furlong, Adam J. Lawther, Cynthia Shannon Weickert, Adam K. Walker
You can read the full article in Brain, Behavior, and Immunity.
More posts featuring Raymond Chan.